| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.94B | 32.79B | 28.17B | 25.10B | 22.24B | 18.88B |
| Gross Profit | 28.16B | 27.36B | 21.49B | 19.08B | 16.97B | 14.39B |
| EBITDA | 21.23B | 20.19B | 16.80B | 15.01B | 12.95B | 11.46B |
| Net Income | 15.57B | 14.97B | 12.87B | 11.20B | 9.93B | 8.69B |
Balance Sheet | ||||||
| Total Assets | 52.45B | 54.16B | 48.08B | 42.45B | 38.72B | 37.67B |
| Cash, Cash Equivalents and Short-Term Investments | 8.22B | 10.90B | 8.77B | 9.18B | 7.41B | 7.89B |
| Total Debt | 18.96B | 19.00B | 18.23B | 15.68B | 14.02B | 13.90B |
| Total Liabilities | 45.73B | 46.41B | 41.57B | 35.45B | 32.35B | 30.26B |
| Stockholders Equity | 6.72B | 7.74B | 6.49B | 6.93B | 6.30B | 7.31B |
Cash Flow | ||||||
| Free Cash Flow | 17.72B | 16.91B | 14.31B | 11.61B | 10.10B | 8.65B |
| Operating Cash Flow | 18.20B | 17.40B | 14.78B | 11.98B | 11.20B | 9.46B |
| Investing Cash Flow | -1.38B | -1.36B | -3.40B | -1.35B | -1.47B | -5.27B |
| Financing Cash Flow | -16.20B | -14.18B | -10.84B | -9.49B | -10.33B | -6.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | $613.75B | 24.01 | 58.90% | 0.69% | 14.37% | 13.59% | |
75 Outperform | $436.67B | 28.67 | 206.12% | 0.54% | 17.06% | 21.18% | |
75 Outperform | $213.90B | 17.46 | 33.95% | 0.84% | 9.41% | 12.00% | |
70 Outperform | $116.47B | 13.06 | 2.86% | 1.05% | 39.21% | -76.14% | |
70 Outperform | $24.05B | 7.23 | 21.41% | 1.34% | -3.18% | 32.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $39.17B | 9.28 | 25.08% | ― | 6.97% | 19.31% |